| Asif A Muhammad, MD | |
|
935 W Exchange Pkwy, Suite 100, Allen, TX 75013-7075 | |
| (214) 383-0938 | |
| (214) 383-9851 |
| Full Name | Asif A Muhammad |
|---|---|
| Gender | Male |
| Speciality | Pulmonary Disease |
| Experience | 33 Years |
| Location | 935 W Exchange Pkwy, Allen, Texas |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1124083258 | NPI | - | NPPES |
| 26731525 | Medicaid | NM | |
| 64033186 | Medicaid | KY |
| Facility Name | Location | Facility Type |
|---|---|---|
| Titus Regional Medical Center | Mount pleasant, TX | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Titus County Hospital District | 0143203257 | 75 |
News Archive
In mice, early weaning and separation from their mothers promotes long-lasting hyperactivity and anxiety. Researchers writing in the open access journal BMC Neuroscience describe the development of this new behavioral model, which they hope to use to investigate the long-term effects of early childhood neglect in people.
Cancer Targeted Technology (CTT), a Seattle-based biotechnology firm focusing on small molecule cancer enzyme inhibitors for the generation of novel diagnostics and therapeutics, today announced that it has signed a Research and License Option Agreement with Bayer Pharma AG, Germany. Under the agreement, CTT will work with Bayer to optimize a novel PET imaging agent based on its unique inhibitor scaffold that recognizes a validated cancer enzyme biomarker.
China Botanic Pharmaceutical Inc., a developer, manufacturer and distributor of botanical products, bio-pharmaceuticals and traditional Chinese medicines ("TCM") in China, today announced financial results for the three months ended January 31, 2011, and reaffirmed guidance for its full fiscal year ending October 31, 2011.
By tinkering with their chemical structures, researchers at the University of California, San Diego School of Medicine have essentially re-invented a class of popular antimicrobial drugs, restoring and in some cases, expanding or improving, their effectiveness against drug-resistant pathogens in animal models.
Researchers in New York City and Guangzhou, China applied the rapidly-developing carbohydrate microarray technology to study an inactivated SARS-coronavirus (SARS-CoV) vaccine and discovered autoimmunogenic activity of this newly identified human viral pathogen.
› Verified 8 days ago
| Entity Name | Titus County Hospital District |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1063548881 PECOS PAC ID: 0143203257 Enrollment ID: O20120525000534 |
News Archive
In mice, early weaning and separation from their mothers promotes long-lasting hyperactivity and anxiety. Researchers writing in the open access journal BMC Neuroscience describe the development of this new behavioral model, which they hope to use to investigate the long-term effects of early childhood neglect in people.
Cancer Targeted Technology (CTT), a Seattle-based biotechnology firm focusing on small molecule cancer enzyme inhibitors for the generation of novel diagnostics and therapeutics, today announced that it has signed a Research and License Option Agreement with Bayer Pharma AG, Germany. Under the agreement, CTT will work with Bayer to optimize a novel PET imaging agent based on its unique inhibitor scaffold that recognizes a validated cancer enzyme biomarker.
China Botanic Pharmaceutical Inc., a developer, manufacturer and distributor of botanical products, bio-pharmaceuticals and traditional Chinese medicines ("TCM") in China, today announced financial results for the three months ended January 31, 2011, and reaffirmed guidance for its full fiscal year ending October 31, 2011.
By tinkering with their chemical structures, researchers at the University of California, San Diego School of Medicine have essentially re-invented a class of popular antimicrobial drugs, restoring and in some cases, expanding or improving, their effectiveness against drug-resistant pathogens in animal models.
Researchers in New York City and Guangzhou, China applied the rapidly-developing carbohydrate microarray technology to study an inactivated SARS-coronavirus (SARS-CoV) vaccine and discovered autoimmunogenic activity of this newly identified human viral pathogen.
› Verified 8 days ago
| Entity Name | Dallas Pulmonary & Critical Care, Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1235402728 PECOS PAC ID: 2163679200 Enrollment ID: O20120824000752 |
News Archive
In mice, early weaning and separation from their mothers promotes long-lasting hyperactivity and anxiety. Researchers writing in the open access journal BMC Neuroscience describe the development of this new behavioral model, which they hope to use to investigate the long-term effects of early childhood neglect in people.
Cancer Targeted Technology (CTT), a Seattle-based biotechnology firm focusing on small molecule cancer enzyme inhibitors for the generation of novel diagnostics and therapeutics, today announced that it has signed a Research and License Option Agreement with Bayer Pharma AG, Germany. Under the agreement, CTT will work with Bayer to optimize a novel PET imaging agent based on its unique inhibitor scaffold that recognizes a validated cancer enzyme biomarker.
China Botanic Pharmaceutical Inc., a developer, manufacturer and distributor of botanical products, bio-pharmaceuticals and traditional Chinese medicines ("TCM") in China, today announced financial results for the three months ended January 31, 2011, and reaffirmed guidance for its full fiscal year ending October 31, 2011.
By tinkering with their chemical structures, researchers at the University of California, San Diego School of Medicine have essentially re-invented a class of popular antimicrobial drugs, restoring and in some cases, expanding or improving, their effectiveness against drug-resistant pathogens in animal models.
Researchers in New York City and Guangzhou, China applied the rapidly-developing carbohydrate microarray technology to study an inactivated SARS-coronavirus (SARS-CoV) vaccine and discovered autoimmunogenic activity of this newly identified human viral pathogen.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Asif A Muhammad, MD 935 W Exchange Pkwy, Suite 100, Allen, TX 75013-7075 Ph: (214) 383-0938 | Asif A Muhammad, MD 935 W Exchange Pkwy, Suite 100, Allen, TX 75013-7075 Ph: (214) 383-0938 |
News Archive
In mice, early weaning and separation from their mothers promotes long-lasting hyperactivity and anxiety. Researchers writing in the open access journal BMC Neuroscience describe the development of this new behavioral model, which they hope to use to investigate the long-term effects of early childhood neglect in people.
Cancer Targeted Technology (CTT), a Seattle-based biotechnology firm focusing on small molecule cancer enzyme inhibitors for the generation of novel diagnostics and therapeutics, today announced that it has signed a Research and License Option Agreement with Bayer Pharma AG, Germany. Under the agreement, CTT will work with Bayer to optimize a novel PET imaging agent based on its unique inhibitor scaffold that recognizes a validated cancer enzyme biomarker.
China Botanic Pharmaceutical Inc., a developer, manufacturer and distributor of botanical products, bio-pharmaceuticals and traditional Chinese medicines ("TCM") in China, today announced financial results for the three months ended January 31, 2011, and reaffirmed guidance for its full fiscal year ending October 31, 2011.
By tinkering with their chemical structures, researchers at the University of California, San Diego School of Medicine have essentially re-invented a class of popular antimicrobial drugs, restoring and in some cases, expanding or improving, their effectiveness against drug-resistant pathogens in animal models.
Researchers in New York City and Guangzhou, China applied the rapidly-developing carbohydrate microarray technology to study an inactivated SARS-coronavirus (SARS-CoV) vaccine and discovered autoimmunogenic activity of this newly identified human viral pathogen.
› Verified 8 days ago
Dr. Yamini K Maddala, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 981 State Highway 121, Suite 1140, Allen, TX 75013 Phone: 469-697-5100 Fax: 469-697-5105 | |
Kathryn Anne White, D.O. Pulmonary Disease Medicare: Medicare Enrolled Practice Location: 1105 Central Expy N Ste 235, Allen, TX 75013 Phone: 972-747-6042 | |
Dr. Olubukola Aduke Okoro, M.D Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 997 Raintree Cir Ste 130, Allen, TX 75013 Phone: 763-443-3926 Fax: 972-390-1050 | |
Deepti Dhavaleshwar, Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 981 State Highway 121, Suite 1140, Allen, TX 75013 Phone: 469-697-5100 Fax: 469-697-5105 | |
Dr. Teresa Dewlett Rajala, M.D. Pulmonary Disease Medicare: Not Enrolled in Medicare Practice Location: 1314 W Mcdermott Dr, Suite 106, Pmb 808, Allen, TX 75013 Phone: 469-252-0022 Fax: 214-383-9587 | |
Dr. Ferzana Mir, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 1105 Central Expy N, Suite 2360, Allen, TX 75013 Phone: 972-838-1892 |